AGN News and Press, Allergan plc From 10/09/19

Nestle S.A. ( OTCPK:NSRGY ) subsidiary Galderma announces positive results from a Phase 2 clinical trial evaluating QM1114, its ready-to-use liquid formulation of botulinum toxin type A, for the treatment of glabellar lines (frown lines). More news on: Nestlé S.A., Allergan plc, Evo...

Investment Thesis Backed by positive results from a phase 02 trial for Major Depressive Disorder ((MDD)), the shares of Axsome Therapeutics, Inc. ( AXSM ) have jumped nearly seven times in 2019 so far. Out of the six clinical trials currently in progress, four data readouts will be availab...

Shares of  biotech giant AbbVie (NYSE: ABBV) gained a healthy 15% in September, according to data from  S&P Global Market Intelligence . The spark? AbbVie's shares perked up after the company's presentation at the Morgan Stanley Healthcare Conference on Sept. 10. While...

Merger activity increased last week with five new deals announced and five deals closing. Deal Statistics: New Deals: The acquisition of Dova Pharmaceuticals (DOVA) by Swedish Orphan Biovitrum AB (BIOVF) for $915 million. Under the terms of the agreement, Dova stockholders will ...

DUBLIN , Oct. 7, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in eye care, today announced the launch of three new over-the-counter (OTC)  REFRESH ® RELIEVA™ products: REFRESH ...

Introduction Allergan ( AGN ) released the prospectus for its merger with AbbVie ( ABBV ) on September 17. Allergan shareholders will vote on the merger on October 14. AbbVie shareholders will not automatically receive this document because AbbVie is issuing less than 20% of its current...

Musings September was full of mixed signals. On one hand, the S&P 500 retested its all-time high (and I had a killer +4.5% month). On the other hand, the wall of worry for this long economic expansion has never seemed more daunting (trade wars, impeachment, earnings recession, etc). ...

The stock market's recent volatility shouldn't concern investors with a long-term outlook. In fact, it's probably a blessing in disguise for the buy-and-hold crowd. Several great stocks, after all, are now trading at attractive valuations.  In the beaten-up healthcare sector, for instance,...

DUBLIN , Oct. 3, 2019 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in ophthalmology, will present new data from investigational Abicipar and Bimatoprost Sustained Release (SR) at the Annual Meeting of the America...

(Source: imgflip) Like many of you, my retirement portfolio is designed to allow me to live comfortably off safe and exponentially growing dividends over time. I own a total of 32 companies, which I buy each week based on the best opportunities the market presents me to fulfill one of ...